June 27: Disability and Rehab/Habilitation Groups to Promote Access to Services/Devices
AAPM&R Submits Comments on IPPS Proposed Rule
Phillips Company Issues Voluntary Worldwide Recall of All Topical Products Due to Concerns of Manufacturing Practices
Why is Advocating for Physiatry Important? Academy Members Share Their Experiences
New Audio Resource: 2016 Annual Assembly Rewind for Residents
Eliquis (apixaban) 5 mg tablets: Recall One Lot- Bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets
AAPM&R Appointed to NQF MAP Workgroup
OIG Recommends CMS Recover EHR Payments
Participants Needed for CMS QPP Research Beginning Next Week - Compensation Provided
AAPM&R Set to Comment on Proposed Payment Rules
July 27 Webinar: Fast and Furious Coding - Interventional Physiatry
Look for Your June Issue of The Physiatrist
Participate in Survey to Improve Hospital Outcomes through Patient Engagement
AAPM&R Begins Development of Quality Measures
Urge Your Senator to Protect Medicaid Coverage for Children and Adults with Disabilities
SpF PLUS-Mini and SpF XL IIB Implantable Spinal Fusion Stimulators by Zimmer Biomet: Class I Recall - Potential for Harmful Chemicals
AAPM&R Members in the News: May 2017
AAPM&R Meets With NIH to Discuss Rehabilitation Research
NEW! Clinical Informatics in Physiatry Supplement and SAE-P
Congratulations to 2017 AAPM&R Award Recipients